ASM
CDIOW icon

ATW SPAC Management’s Cardio Diagnostics Holdings Inc Warrant CDIOW Stock Holding History

ATW SPAC Management’s Portfolio CDIOW Stock Details CDIOW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-60,540
Closed -$2.35K – 160
2024
Q2 		$2.35K Hold
60,540
– – ﹤0.01% 150
2024
Q1 		$6.44K Hold
60,540
– – 0.01% 135
2023
Q4 		$10.5K Buy
+60,540
New +$6.02K 0.02% 111

Other funds holding CDIOW

BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $4.33B AUM 1.35% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

ATW SPAC Management's CDIOW Position: Q3 2025 in Review

ATW SPAC Management held its Cardio Diagnostics Holdings Inc Warrant (CDIOW) position steady in Q3 2025 at 60,540 shares worth $1.24K. The position accounts for ﹤0.01% of the portfolio, ranked #150.

ATW SPAC Management first reported a position in CDIOW in Q1 2022 and has held it in 12 quarters since. The position peaked at $19.4K in Q1 2023. 10 funds tracked by Wall St. Rank hold CDIOW as of Q3 2025.

  • ATW SPAC Management held 60,540 shares of Cardio Diagnostics Holdings Inc Warrant worth $1.24K as of Q3 2025.
  • ATW SPAC Management left its Cardio Diagnostics Holdings Inc Warrant share count unchanged in Q3 2025.
  • Cardio Diagnostics Holdings Inc Warrant made up ﹤0.01% of ATW SPAC Management's portfolio in Q3 2025, its #150 holding.
  • ATW SPAC Management first reported a position in Cardio Diagnostics Holdings Inc Warrant in Q1 2022 and has held it in 12 quarters since.
  • ATW SPAC Management's Cardio Diagnostics Holdings Inc Warrant position peaked at $19.4K in Q1 2023.
  • 10 funds tracked by Wall St. Rank held Cardio Diagnostics Holdings Inc Warrant as of Q3 2025.

Based on ATW SPAC Management's 13F filing for Q3 2025, filed 12 Nov 2025.